Rigid Endoscopes Market Size, Share & Trends Analysis Report By Product (Laparoscopes, Arthroscopes, Bronchoscopes, Cystoscopes), By End-use (Hospitals, Outpatient Facilities), By Region, And Segment Forecasts, 2023 - 2030

Report Overview

The global rigid endoscopes market size was valued at USD 6.0 billion in 2022 and is projected to expand at a compound annual growth rate (CAGR) of 7.1% from 2023 to 2030. The growing demand for minimally invasive surgical procedures, especially laparoscopy, cystoscopy, and others, is boosting the market growth. High preference among endoscopists to obtain better visualization of organs in surgery and the high number of surgeries related to chronic diseases conducted worldwide, which is leading to the demand for rigid endoscopes, are driving the growth of the overall market. The COVID-19 pandemic is expected to have affected the demand for rigid endoscopes, as during the pandemic, the majority of elective surgeries were postponed as physicians gave preference to COVID-19-infected patients. In the post-pandemic period, this scenario is changing as many elective surgeries have resumed owing to the rising burden of chronic diseases worldwide. For instance, according to Cancer Tomorrow, the incidence of cancer accounted for 13.3 million in 2020 and this number is expected to rise to 30.3 million in 2040. This is expected to increase the rate of surgeries in the post-pandemic period and thus support market growth.

There is a growing demand for minimally invasive surgeries worldwide. Smaller incisions help in the faster healing of wounds and owing to this reason, patients don't need to visit hospitals frequently, because there are not many cuts or stitches. In contrast, traditional open surgeries require long incisions through the muscles and take more time to heal. This is one of the major factors supporting the demand for endoscopy procedures. Furthermore, rigid endoscopes provide high-definition images of organs; owing to this reason, there is a wide demand for rigid endoscopes for minimally invasive surgeries, which is promoting the market growth.

A significant number of people worldwide suffer from chronic diseases such as liver cancer, endometriosis, and others. As per 2021 factsheets provided by WHO, around 190 million women of reproductive age suffer from endometriosis globally. Similarly, uterine fibroids (UFs), which are also referred to as uterine leiomyoma (UL), fibroma, or leiomyoma, are among the most common tumors found in the female reproductive system. For instance, a recent study in 2022 showed that the likelihood of having UFs is estimated to be between 20-77%, and the chances of having this condition are estimated to be between 40-60% among women under the age of 35, and 70-80% among women over the age of 50. Additionally, a previous study reported that black women in the United States are more prone to this condition, with an occurrence rate of 59%. All these diseases are treated through laparoscopic surgery. The high burden of these diseases is expected to improve laparoscopic procedures in the future and thus support the demand for rigid endoscopes.

Product Insights

The laparoscopes segment dominated the market and accounted for the largest revenue share of 27.0% in 2022. Laparoscopies are generally done for gastrointestinal and gynecological cases. Diseases such as endometriosis, hernias, gall bladder cancer, ovarian cancer, and others are generally treated by laparoscopies. For instance, according to World Cancer Research Fund International, ovarian cancer is one of the most common types of cancer, and in the year 2020, there were more than 313,000 new cases of ovarian cancer worldwide. The high burden of these diseases is expected to improve the number of laparoscopic procedures worldwide and thus support the demand for rigid laparoscopes.

The ureteroscopes segment is anticipated to witness the fastest growth over the forecast period, owing to the increasing prevalence of kidney-related disorders such as ureteral strictures, kidney and ureteral stones, and urothelial cancers, which are some of the major reasons supporting the growth of the market segment. For instance, according to the National Kidney Foundation, more than 500,000 patients visit emergency departments each year with kidney stone-related illnesses. The high incidence of these diseases is expected to support the demand for rigid endoscopes for urethral surgeries.

End-use Insights

The outpatient facilities segment dominated the market and accounted for the highest revenue share of more than 50% based on end-use in 2022. The market is segmented into hospitals and outpatient facilities based on end-use. This high growth is due to advantageous reimbursement regulations and the widespread use of endoscopic devices in outpatient clinics. The market for outpatient facilities is anticipated to develop at the fastest rate during the projected period due to the rising need for healthcare services that are both affordable and convenient. For many patients, these facilities are a more economical option because they provide medical care that does not necessitate an overnight stay in the hospital. These factors further support segmental market growth. The segment is anticipated to grow at the fastest rate during the forecast period.

The hospital segment is expected to grow lucratively over the forecast period. The majority of endoscopic surgeries, such as laparoscopy, arthroscopy, ureteroscopy, cystoscopy, and others, are conducted in hospitals. Hospitals also have experienced surgeons owing to which the majority of patients opt to go to a hospital for endoscope-related surgeries. The significant number of people undergoing endoscopic surgeries in hospitals is expected to support the segment market.

Regional Insights

North America dominated the rigid endoscopes market and accounted for the largest revenue share of 41.8% in 2022. This is due to the rising popularity of elective endoscopic surgeries in the region, increased healthcare spending, and the rapidly growing geriatric population. The increasing prevalence of cancer and gastrointestinal disorders in the U.S. is expected to further support the growth of the regional market. For instance, the American Cancer Society stated that in 2021, over 1.9 million new cancer cases were identified in the U.S. All the above-mentioned factors are expected to support the market growth in the region.

The Asia Pacific region is expected to witness the fastest growth over the forecast period. The high burden of chronic diseases, the demand for minimally invasive procedures, rising disposable income, and high healthcare spending are expected to improve the demand for rigid endoscopes. Also, the expansion of the region's healthcare infrastructure as well as the rising number of hospitals and diagnostic facilities in the region is anticipated to support the regional market's expansion.

Key Companies & Market Share Insights

Competition is intense amongst the existing players due to the rising demand for endoscopy devices for various treatment and diagnostic procedures. In addition, technological advancements in the field of endoscopic instruments by key players are further increasing the competition. Major players are focused on obtaining approvals for their products, launching new products, undergoing partnerships, and adopting other strategies. For instance, in January 2023, Pristine Surgical received USFDA approval for its 4K single-use surgical arthroscope device. The arthroscope was launched to improve arthroscopy procedures for surgeons. Some of the prominent players in the global rigid endoscopes market include:

• Olympus Corporation

• Ethicon U.S., LLC

• Boston Scientific Corporation

• Karl Storz GmbH & Co. KG

• Stryker

• PENTAX Medical

• Richard Wolf

• Medtronic

Rigid Endoscopes Market Report Scope

Global Rigid Endoscopes Market Report Segmentation

This report forecasts revenue growth at global, regional, & country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For the purpose of this study, Grand View Research has segmented the global rigid endoscopes market report on the basis of product, end-use, and region:

• Product Outlook (Revenue, USD Million, 2018 - 2030)

  • Laparoscopes

  • Arthroscopes

  • Ureteroscopes

  • Cystoscopes

  • Gynecology Endoscopes

  • Neuroendoscopes

  • Bronchoscopes

  • Hysteroscopes

  • Laryngoscopes

  • Sinuscopes

  • Otoscopes

  • Sigmoidoscopes

  • Pharygnoscopes

  • Duodenoscopes

  • Nasopharygnoscopes

  • Rhinoscopes

• End-use Outlook (Revenue, USD Million, 2018 - 2030)

  • Hospitals

  • Outpatient Facilities

• Regional Outlook (Revenue, USD Million, 2018 - 2030)

  • North America

    • U.S.

    • Canada

  • Europe

    • U.K.

    • Germany

    • Spain

    • France

    • Italy

    • Sweden

    • Denmark

    • Norway

  • Asia Pacific

    • Japan

    • China

    • India

    • Australia

    • South Korea

    • Thailand

  • Latin America

    • Brazil

    • Mexico

    • Argentina

  • Middle East & Africa

    • South Africa

    • Saudi Arabia

    • UAE

    • Kuwait